Cytoreductive surgery in ovarian carcinoma: feasibility and morbidity

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-07-31

This study examined cytoreductive surgery for ovarian carcinoma, finding improved optimal cytoreduction rates with experience and that bowel resection did not increase morbidity, with stapling devices facilitating acceptable colonic reanastomosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-25 · read from full text

This study evaluated the feasibility and morbidity of primary cytoreductive surgery for ovarian carcinoma in 70 patients treated at the University of California, Los Angeles, between 1974 and 1984. The researchers found that optimal cytoreduction rates improved significantly from 56.4% to 87.1% as surgical experience increased over time. Common postoperative complications included fever and prolonged ileus, while bowel resection was necessary in 20% of cases without increasing overall morbidity. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Between 1974 and 1984, 70 patients underwent primary cytoreductive surgery for ovarian carcinoma at the University of California at Los Angeles. During the period of January 1974 to December 1978, optimal cytoreduction was achieved in 56.4% of the patients. With increased experience, this figure improved to 87.1% in the period of January 1979 to December 1983. The most common morbidity associated with the procedure was fever and prolonged ileus. Bowel resection was required in 20% of the patients and was not associated with increased morbidity. More liberal use of the end-to-end anastomosis stapling device facilitated low colon reanastomosis without colostomy, which contributed to the improved patient acceptance.
Full text 931 characters · extracted from oa-doi-fallback · click to expand
Cytoreductive Surgery in Ovarian Carcinoma Feasibility and Morbidity - A. PETER M. HEINTZ - NEVILLE F. HACKER - JONATHAN S. BEREK - THANNE P. ROSE - ALAN K. MUNOZ - LEO D. LAGASSE Between 1974 and 1984, 70 patients underwent primary cytoreductive surgery for ovarian carcinoma at the University of California at Los Angeles. During the period of January 1974 to December 1978, optimal cytoreduction was achieved in 56.4% of the patients. With increased experience, this figure improved to 87.1% in the period of January 1979 to December 1983. The most common morbidity associated with the procedure was fever and prolonged ileus. Bowel resection was required in 20% of the patients and was not associated with increased morbidity. More liberal use of the end-to-end anastomosis stapling device facilitated low colon reanastomosis without colostomy, which contributed to the improved patient acceptance.(Obstet Gynecol 67:783, 1986)

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Adenocarcinoma Adenocarcinoma, Mucinous Carcinoma Endometriosis Ovarian Neoplasms Adenocarcinoma Adenocarcinoma Adenocarcinoma, Mucinous Adenocarcinoma, Mucinous Aged Carcinoma Carcinoma Endometriosis Endometriosis Female Fever Fever Humans Intestinal Obstruction Intestinal Obstruction

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-13T09:25:22.628771+00:00
pubmed
last seen: 2026-05-13T22:09:40.384591+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine